Spinnaker Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$516K Buy
10,772
+46
+0.4% +$1.98K 0.03% 216
2026
Q1
$394K Hold
10,726
0.02% 225
2025
Q4
$546K Buy
10,726
+1,186
+12% +$60.6K 0.03% 199
2025
Q3
$529K Buy
9,540
+40
+0.4% +$2.34K 0.03% 199
2025
Q2
$656K Sell
9,500
-70
-0.7% -$4.76K 0.04% 185
2025
Q1
$665K Sell
9,570
-45
-0.5% -$3.72K 0.04% 174
2024
Q4
$827K Hold
9,615
0.05% 155
2024
Q3
$1.14M Buy
9,615
+100
+1% +$13.3K 0.07% 136
2024
Q2
$1.36M Hold
9,515
0.09% 128
2024
Q1
$1.22M Sell
9,515
-45
-0.5% -$5.36K 0.08% 131
2023
Q4
$989K Sell
9,560
-104
-1% -$10.3K 0.07% 141
2023
Q3
$879K Hold
9,664
0.07% 137
2023
Q2
$782K Hold
9,664
0.06% 137
2023
Q1
$769K Hold
9,664
0.06% 133
2022
Q4
$654K Hold
9,664
0.05% 150
2022
Q3
$481K Sell
9,664
-26
-0.3% -$1.39K 0.04% 173
2022
Q2
$540K Hold
9,690
0.04% 177
2022
Q1
$538K Hold
9,690
0.04% 182
2021
Q4
$543K Hold
9,690
0.03% 191
2021
Q3
$465K Hold
9,690
0.03% 191
2021
Q2
$406K Hold
9,690
0.03% 208
2021
Q1
$326K Buy
+9,690
New +$345K 0.02% 212

Other funds holding NVO

Spinnaker Trust's NVO Position: Q2 2026 in Review

Spinnaker Trust increased its Novo Nordisk (NVO) stake by 0.43% in Q2 2026, buying an estimated $1.98K and bringing the position to 10,772 shares worth $516K. The position accounts for 0.03% of the portfolio, ranked #216.

Spinnaker Trust first reported a position in NVO in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.36M in Q2 2024. 884 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Spinnaker Trust held 10,772 shares of Novo Nordisk worth $516K as of Q2 2026.
  • Spinnaker Trust bought 46 Novo Nordisk shares in Q2 2026, an estimated $1.98K.
  • Novo Nordisk made up 0.03% of Spinnaker Trust's portfolio in Q2 2026, its #216 holding.
  • Spinnaker Trust first reported a position in Novo Nordisk in Q1 2021 and has held it in 22 quarters since.
  • Spinnaker Trust's Novo Nordisk position peaked at $1.36M in Q2 2024.
  • 884 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Spinnaker Trust's 13F filing for Q2 2026, filed 3 Aug 2026.